Lpl Financial LLC Ampio Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $1,748 - $458,850	-21,850 Reduced 26.73%	59,879 $4,000
Q2 2022 Aug 12, 2022	BUY	$0.16 - $0.47 $282 - $829	1,765 Added 2.21%	81,729 $14,000
Q1 2022 May 16, 2022	BUY	$0.42 - $0.62 $2,709 - $3,999	6,450 Added 8.77%	79,964 $38,000
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $13,736 - $41,944	-24,529 Reduced 25.02%	73,514 $42,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $12,730 - $18,937	-10,521 Reduced 9.69%	98,043 $163,000
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $71,625 - $90,909	45,914 Added 73.29%	108,564 $181,000
Q1 2021 May 14, 2021	SELL	$1.36 - $2.49 $7,344 - $13,446	-5,400 Reduced 7.94%	62,650 $106,000
Q4 2020 Feb 12, 2021	SELL	$0.75 - $2.76 $9,937 - $36,570	-13,250 Reduced 16.3%	68,050 $108,000
Q3 2020 Nov 09, 2020	BUY	$0.61 - $1.17 $2,928 - $5,616	4,800 Added 6.27%	81,300 $78,000
Q2 2020 Aug 13, 2020	SELL	$0.47 - $0.72 $11,280 - $17,280	-24,000 Reduced 23.88%	76,500 $49,000
Q1 2020 May 14, 2020	BUY	$0.36 - $0.74 $3,495 - $7,184	9,709 Added 10.69%	100,500 $42,000
Q3 2019 Nov 13, 2019	BUY	$0.38 - $0.52 $926 - $1,268	2,439 Added 2.76%	90,791 $45,000
Q2 2019 Aug 09, 2019	BUY	$0.39 - $0.7 $34,457 - $61,846	88,352 New	88,352 $34,000
Q3 2018 Nov 14, 2018	SELL	$0.44 - $3.02 $13,200 - $90,600	-30,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $3,888 - $6,264	1,800 Added 6.38%	30,000 $102,000
Q4 2017 Feb 14, 2018	BUY	$0.68 - $4.19 $19,176 - $118,158	28,200 New	28,200 $115,000
Q3 2017 Nov 14, 2017	SELL	$0.38 - $0.66 $3,876 - $6,732	-10,200 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	10,200	10,200 $5,000

Others Institutions Holding AMPE

# of Institutions

Shares Held

96.6K

Call Options Held

Put Options Held

Ntb Financial Corp Centennial, CO

96.6K
Shares

$0
0.01% of portfolio

View Full List

About Ampio Pharmaceuticals, Inc.

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

More about AMPE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account